Skip to content
10-Q

Quarterly Report

GALECTIN THERAPEUTICS INC GALT

0001140361-25-042116

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 64.47M sh
Shares Diluted Q3 2025 · Sep 30, 2025 64.21M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.62M sh
Shares Diluted Q3 2025 · Sep 30, 2024 62.28M sh
Shares Diluted Q3 2025 · Sep 30, 2024 62.16M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$17.83M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$28.98M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $11.53M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $15.12M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$125.3M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$118.89M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$104.79M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$94.2M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$83.87M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$61.96M
Current Liabilities Q3 2025 · Sep 30, 2025 $136.45M
Current Liabilities Q3 2025 · Dec 31, 2024 $35.41M
Total Liabilities Q3 2025 · Sep 30, 2025 $136.45M
Total Liabilities Q3 2025 · Dec 31, 2024 $120.57M
Current Assets Q3 2025 · Sep 30, 2025 $12.73M
Current Assets Q3 2025 · Dec 31, 2024 $17.25M
Total Assets Q3 2025 · Sep 30, 2025 $12.87M
Total Assets Q3 2025 · Dec 31, 2024 $17.5M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.13
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.40
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.57
Eps Basic Q3 2025 · Sep 30, 2025 −$0.13
Eps Basic Q3 2025 · Sep 30, 2025 −$0.40
Eps Basic Q3 2025 · Sep 30, 2024 −$0.18
Eps Basic Q3 2025 · Sep 30, 2024 −$0.57
Sga Expense Q3 2025 · Sep 30, 2025 $1.59M
Sga Expense Q3 2025 · Sep 30, 2025 $4.36M
Sga Expense Q3 2025 · Sep 30, 2024 $1.47M
Sga Expense Q3 2025 · Sep 30, 2024 $4.54M
Rd Expense Q3 2025 · Sep 30, 2025 $2.61M
Rd Expense Q3 2025 · Sep 30, 2025 $12.36M
Rd Expense Q3 2025 · Sep 30, 2024 $7.6M
Rd Expense Q3 2025 · Sep 30, 2024 $25.46M
Net Income Q3 2025 · Sep 30, 2025 −$8.18M
Net Income Q3 2025 · Sep 30, 2025 −$25.34M
Net Income Q3 2025 · Sep 30, 2024 −$11.22M
Net Income Q3 2025 · Sep 30, 2024 −$35.08M
Operating Income Q3 2025 · Sep 30, 2025 −$4.2M
Operating Income Q3 2025 · Sep 30, 2025 −$16.72M
Operating Income Q3 2025 · Sep 30, 2024 −$9.07M
Operating Income Q3 2025 · Sep 30, 2024 −$30.01M